NEW YORK, May 22 (GenomeWeb News) - The National Institutes of Health awarded GenTel BioSciences a two-year, $1.2-million grant to develop a protein chip that can diagnose respiratory allergies, the company said today.
The test kit will use a few drops of blood to identify patient allergies, Bryce Nelson, GenTel's vice president of R&D, said in a statement. The chip will use multiplex assays to rapidly test a patient's blood against several potential allergies at once.
GenTel hopes the test will replace puncture tests, where extracts are inserted under the patient's skin in multiple punctures. Existing alternatives include venous blood draws, which require sizeable amounts of blood and have a slow turnaround time for results.
As part of the Phase II SBIR grant, GenTel plans to place beta-testing instruments in doctor's offices in the second year of the project.
GenTel has received six SBIR awards, totaling over $2 million, in the last three years. In 2005, the company completed a Phase I SBIR on an allergy chip concept.